These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31673792)

  • 1. Protective effect of taurine against doxorubicin-induced cardiotoxicity in rats: echocardiographical and histological findings.
    Barış VÖ; Gedikli E; Yersal N; Müftüoğlu S; Erdem A
    Amino Acids; 2019 Nov; 51(10-12):1649-1655. PubMed ID: 31673792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spironolactone Attenuates Doxorubicin-induced Cardiotoxicity in Rats.
    Liu G; Liu Y; Wang R; Hou T; Chen C; Zheng S; Dong Z
    Cardiovasc Ther; 2016 Aug; 34(4):216-24. PubMed ID: 27097055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes.
    Karhu ST; Kinnunen SM; Tölli M; Välimäki MJ; Szabó Z; Talman V; Ruskoaho H
    Arch Toxicol; 2020 Jun; 94(6):2113-2130. PubMed ID: 32185414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early myocardial changes induced by doxorubicin in the nonfailing dilated ventricle.
    Rodrigues PG; Miranda-Silva D; Costa SM; Barros C; Hamdani N; Moura C; Mendes MJ; Sousa-Mendes C; Trindade F; Fontoura D; Vitorino R; Linke WA; Leite-Moreira AF; Falcão-Pires I
    Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H459-H475. PubMed ID: 30525890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empagliflozin Significantly Prevents the Doxorubicin-induced Acute Cardiotoxicity via Non-antioxidant Pathways.
    Barış VÖ; Dinçsoy AB; Gedikli E; Zırh S; Müftüoğlu S; Erdem A
    Cardiovasc Toxicol; 2021 Sep; 21(9):747-758. PubMed ID: 34089496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity.
    Nabati M; Janbabai G; Baghyari S; Esmaili K; Yazdani J
    J Cardiovasc Pharmacol; 2017 May; 69(5):279-285. PubMed ID: 28141699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin.
    Quagliariello V; De Laurentiis M; Rea D; Barbieri A; Monti MG; Carbone A; Paccone A; Altucci L; Conte M; Canale ML; Botti G; Maurea N
    Cardiovasc Diabetol; 2021 Jul; 20(1):150. PubMed ID: 34301253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity.
    Galán-Arriola C; Villena-Gutiérrez R; Higuero-Verdejo MI; Díaz-Rengifo IA; Pizarro G; López GJ; Molina-Iracheta A; Pérez-Martínez C; García RD; González-Calle D; Lobo M; Sánchez PL; Oliver E; Córdoba R; Fuster V; Sánchez-González J; Ibanez B
    Cardiovasc Res; 2021 Mar; 117(4):1132-1143. PubMed ID: 32597960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity.
    Russo M; Guida F; Paparo L; Trinchese G; Aitoro R; Avagliano C; Fiordelisi A; Napolitano F; Mercurio V; Sala V; Li M; Sorriento D; Ciccarelli M; Ghigo A; Hirsch E; Bianco R; Iaccarino G; Abete P; Bonaduce D; Calignano A; Berni Canani R; Tocchetti CG
    Eur J Heart Fail; 2019 Apr; 21(4):519-528. PubMed ID: 30843309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qishen Yiqi Dropping Pills Ameliorates Doxorubicin-induced Cardiotoxicity in Mice via Enhancement of Cardiac Angiogenesis.
    Wang L; Wang L; Zhou X; Ruan G; Yang G
    Med Sci Monit; 2019 Apr; 25():2435-2444. PubMed ID: 30943187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress.
    Li W; Xu B; Xu J; Wu XL
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):192-7. PubMed ID: 19143757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective role of a magnolol and honokiol complex in the prevention of doxorubicin-mediated cardiotoxicity in adult rats.
    Aktay I; Bitirim CV; Olgar Y; Durak A; Tuncay E; Billur D; Akcali KC; Turan B
    Mol Cell Biochem; 2024 Feb; 479(2):337-350. PubMed ID: 37074505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
    Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
    Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise preconditioning provides long-term protection against early chronic doxorubicin cardiotoxicity.
    Hydock DS; Lien CY; Jensen BT; Schneider CM; Hayward R
    Integr Cancer Ther; 2011 Mar; 10(1):47-57. PubMed ID: 21382960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodelling.
    Chan BYH; Roczkowsky A; Cho WJ; Poirier M; Sergi C; Keschrumrus V; Churko JM; Granzier H; Schulz R
    Cardiovasc Res; 2021 Jan; 117(1):188-200. PubMed ID: 31995179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Role of Silymarin in Early Doxorubicin-induced Cardiac Dysfunction in Children with Acute Lymphoblastic Leukemia.
    Hagag AA; El Shehaby WA; El-Abasy AI; Mabrouk MM
    Infect Disord Drug Targets; 2019; 19(2):133-140. PubMed ID: 30073931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coenzyme Q10 Cardioprotective Effects Against Doxorubicin-Induced Cardiotoxicity in Wistar Rat.
    Botelho AFM; Lempek MR; Branco SEMT; Nogueira MM; de Almeida ME; Costa AG; Freitas TG; Rocha MCRC; Moreira MVL; Barreto TO; Santos JC; Lavalle G; Melo MM
    Cardiovasc Toxicol; 2020 Jun; 20(3):222-234. PubMed ID: 31435888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine is protective against doxorubicin-induced cardiotoxicity in rat.
    Kelishomi RB; Ejtemaeemehr S; Tavangar SM; Rahimian R; Mobarakeh JI; Dehpour AR
    Toxicology; 2008 Jan; 243(1-2):96-104. PubMed ID: 17988779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid reduces doxorubicin-induced cardiomyopathy by modulating endothelial nitric oxide synthase.
    Octavia Y; Kararigas G; de Boer M; Chrifi I; Kietadisorn R; Swinnen M; Duimel H; Verheyen FK; Brandt MM; Fliegner D; Cheng C; Janssens S; Duncker DJ; Moens AL
    J Cell Mol Med; 2017 Dec; 21(12):3277-3287. PubMed ID: 28608983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy.
    Efentakis P; Varela A; Chavdoula E; Sigala F; Sanoudou D; Tenta R; Gioti K; Kostomitsopoulos N; Papapetropoulos A; Tasouli A; Farmakis D; Davos CH; Klinakis A; Suter T; Cokkinos DV; Iliodromitis EK; Wenzel P; Andreadou I
    Cardiovasc Res; 2020 Mar; 116(3):576-591. PubMed ID: 31228183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.